24/7 Patient Assistance: 760-405-8205

Gerald H. Clamon, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

Holden Comprehensive Cancer Center

specialties & services

Biological Therapy/Immunotherapy Chemotherapy Targeted Therapy Thoracentesis

  • Bio & Insurance Information

    A highly experienced medical oncologist, Dr. Gerald Clamon is currently practicing at the Holden Comprehensive Cancer Center in Iowa City. He completed the Washington University School of Medicine in St. Louis and went on to residency at the Barnes-Jewish Hospital. He completed his medical studies with a fellowship at the University of Iowa Hospitals and Clinics and National Institutes of Health in Bethesda. Dr. Clamon specializes in hematology, oncology and treating different types of lung cancer, mainly mesothelioma, which requires a great deal of expertise to be treated effectively. Dr. Gerald Clamon has published several important works in the field, with many being used today to develop improved treatment techniques.

  • Education & Training

    dept_icon

    Washington University School of Medicine, St. Louis, MO

    Medical School

    dept_icon

    Barnes-Jewish Hospital, St Louis, MO

    Residency

    dept_icon

    University of Iowa Hospitals and Clinics, Iowa City, IA National Institutes of Health, Bethesda, MD

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Holden Comprehensive Cancer Center

    Languages: English/Spanish

    (319) 356-4200

    200 Hawkins Dr

    Iowa City, Iowa 52242

    Read More
  • Publications & Memberships

    Dr. Gerald H. Clamon has contributed to 4 publications.

    Germline mutations predisposing to non-small cell lung cancer.

    Clamon, G. H.,Bossler, A. D.,Hejleh, T. A.,Furqan, M.; Fam. Cancer.

    See more >>

    Differences in clinical trial patient attributes and outcomes according to enrollment setting.

    Lamont, E.B., Landrum, M.B., Keating, N.L., Archer, L., Lan, L., Strauss, G.M., Lilenbaum, R., Niell, H.B., Maurer, L.H., Kosty, M.P., Miller, A.A., Clamon, G.H

    See more >>

    Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.

    Givens, D.J., Karnell, L.H., Gupta, A.K., Clamon, G.H., Pagedar, N.A., Chang, K.E., Van Daele, D.J., Funk, G.F.; Arch Otolaryngol Head Neck Surg.

    See more >>

    Mortality related to neoadjuvant therapy and surgery for stage III non-small-cell lung cancer.

    Clamon, G.H., Parekh, K.R.; Clin Lung Cancer.

    See more >>

    Memberships

    American Society of Clinical Oncology